Undermining the endothelium by ablation of MAPK-MEF2 signaling
- PMID: 15085188
- PMCID: PMC385412
- DOI: 10.1172/JCI21497
Undermining the endothelium by ablation of MAPK-MEF2 signaling
Abstract
Numerous stimuli activate Big MAPK-1 (BMK1), an MAPK that activates the myocyte enhancer factor-2 (MEF2) transcription factor. Conditional gene deletion showed BMK1 to be required for survival of endothelial cells. An active form of MEF2C could partially bypass the requirement for BMK1 for endothelial cell survival in vitro. These findings reveal an essential role for BMK1-MEF2 signaling in an endothelial cell survival pathway and raise interesting questions about the molecular basis of this response.
Figures

Comment on
-
Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure.J Clin Invest. 2004 Apr;113(8):1138-48. doi: 10.1172/JCI19890. J Clin Invest. 2004. PMID: 15085193 Free PMC article.
References
-
- Raman M, Cobb MH. MAP kinase modules: many roads home. Curr. Biol. 2003;13:R886–R888. - PubMed
-
- Fukuhara S, Marinissen MJ, Chiariello M, Gutkind JS. Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Galpha q and Galpha 12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras and Rho-independent pathway. J. Biol. Chem. 2000;275:21730–21736. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous